(Il Sole 24 Ore Radiocor) - Milano, 6 mag - Smith+Nephew, a UK manufacturer of medical equipment, said that first quarter revenue totalled 1.501 billion pounds, up a reported 6.6% and an underlying 3.1%.

When adjusted to the number of sales days, underlying revenue growth was 4.7%.

The company maintained its full year guidance unchanged. It said that it is on track to deliver underlying revenue growth of around 6%, about 8% trading profit growth, around 800 million dollars free cash flow, and more than 10% adjusted return on invested capital (ROIC).

Smith+Nephew announced a share buyback of 500 million dollars to be completed within the next 12 months. The new buyback.

follows the 500 million dollar buyback completed in 2025.

(RADIOCOR) 06-05-26 09:10:38 (0222) 5 NNNN